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Purpose/Objective: To evaluate the relevance of rotational shift in 
IGRT prostate RapidArc and to validate the added value of Protura 6 
degree of freedom (DOF) Robotic Patient Positioning System (CIVCO 
Medical Solution) to improve setup accuracy with the Cone Beam CT 
scanner (CBCT). 
 Materials and Methods: We enrolled patients with cT3aN0M0 low risk 
for nodal involvement prostate cancer. RapidArc simultaneous 
integrated boost treatment plans were made; a total dose of 80Gy 
(200cGy/ fraction) to prostate and 72Gy (180cGy/fraction) to the 
seminal vesicle base were delivered. Patients in supine position with 
dual leg immobilization (CIVCO support system) underwent to 
simulation a computerized tomography (CT) scan for radiotherapy 
planning. A CBCT was performed daily before dose delivery. Images 
were then compared with the simulation CT images in order to 
determine the magnitude of set-up error and organ motion. 
Translational (Lateral, Vertical and Longitudinal) and Rotational 
(Pitch, Yaw and Roll) shifts were identified with manual and/or 
automatic 3D matching (Varian 6D Online Review System). The 
collected shifts were applied on the Protura Robotic Patient 
Positioning System to obtain a more accurate alignment. Mean 
translation and rotation shifts were calculated. The 3D-vector of 
displacement was also worked out and the total procedure time was 
recorded. 
Results: From October to December 2012, we enrolled 5 patients with 
a median age of 76 yrs (range 64-78). One hundred and thirty-two 
CBCT studies were performed and compared to CT images. The mean 
(±SD) interfraction displacement in vertical, lateral and longitudinal 
direction was -0.2 ± 0.3 cm, 0.0 ± 0.3 cm and -0.2 ± 0.5 cm 
respectively. The maximal translation setup shift was 1.4 cm 
vertically, 1.6 cm longitudinally and 1 cm laterally, with 98% of the 
shifts < 1 cm. The mean (±SD) 3D vector of displacement was 0.3 ± 0.7 
cm. The mean (±SD) interfraction rotations were: Pitch= -0.4 ± 1.1°, 
Roll= -0.5 ± 1.2° and Yaw= 0.1 ± 0.7°. The maximal rotation error was 
2.8° for Pitch, 3.8° for Roll and 2.1° for Yaw, with 91% of the 
rotations < 2°. No correlation was observed between the magnitude of 
translational and rotational shift. The mean time for all treatment 
procedures was 14.52 ± 2.02 minutes. Despite the manual transfer of 
data to the Protura software in this phase, no more than one extra 
minute was required compared to the standard procedure. 
Conclusions: Our preliminary data shows that the Protura Robotic 
Patient Positioning System is essential to improve accuracy in the 
IGRT era. It underlines the necessity to perform rotational shifts, 
especially in prostate treatments. Correlation between volumetric and 
geometrical shift data and evaluation of its dosimetrical impact on 
adaptive dose is ongoing. 
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Purpose/Objective: To analyse inter-fractional prostate bed motion 
(PBM) and to quantify its components using an endorectal balloon 
(ERB) and daily cone beam computed tomography (CBCT). 
Materials and Methods: A total of 1,348 CBCT images from 46 patients 
who underwent postprostatectomy radiotherapy were analysed. Total 
set-up error was defined as the shift from the skin mark to the 
prostate bed matching, based on anterior rectal wall stretching by the 
ERB. Prostate bed motion (PBM) was defined as the difference 
between the total set-up error and bony misalignment (BM).  
Results: The systematic errors for the total set-up error were 1.0, 
1.3, and 1.0 mm in the right-left, anterior-posterior, and superior-
inferior directions, respectively, with random errors of 1.9, 2.4, and 
1.9 mm, respectively. Systematic errors were 1.6, 1.6, and 0.3 mm for 
BM and 0.8, 1.1, and 0.9 mm for PBM, with random errors of 2.4, 2.5, 
and 1.1 mm for BM and 1.8, 2.2, and 1.9 mm for PBM. 
Conclusions: Planning target volume margins of <5 mm were needed 
to include 95% of the inter-fractional variations when using an ERB. 
The BM was the main component of the total set-up error, which 
indicated that inter-fractional PBM was well controlled by the ERB. 
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Purpose/Objective: Whole-pelvis radiotherapy (WPRT) may have a 
role in post-prostatectomy (POSTOP), both adjuvant (ADV) and salvage 
(SALV) radiotherapy (RT) after radical prostatectomy for prostate 
cancer (PCa). Haematological toxicity (HT) from WPRT for PCa has 
never been evaluated. Moreover, HT from WPRT has thus far been 
analyzed only in patients treated with concurrent chemoradiation. A 
prospective evaluation of HT in PCa patients receiving postoperative 
WPRT was therefore activated.  
Materials and Methods: From November 2011 to October 2012, 50 
consecutive patients receiving WPRT as a part of ADV (n=29) or SALV 
(n=21) POSTOP RT were analyzed. The collection of a complete blood 
sample before RT start (baseline), at RT mid-point, at RT end, at 90 
days from RT completion and subsequently every six months for 3 
years was planned. This first analysis is aimed at quantifying early 
blood cell changes on the first 50 patients with complete baseline, 
mid-point and end RT data; for 25/50, data at 90 days were also 
available. Patients were treated with conventionally fractionated (CF, 
1.80 Gy/fraction, n=16) or moderately hypofractionated (HYPO, 2.35-
2.60 Gy/fr, median 2.35, n=34) RT, with IMRT (n=13), Volumetric Arc 
(VMAT, n=31) or Helical Tomotherapy (n=6) technique. For CF and 
HYPO, RT dose to the prostatic bed ranged from 72 to 77.4 Gy and 
from 65.8 to 72.8 Gy, respectively, while WPRT dose was 50.4 and 
51.8 Gy, respectively. Mean and median values of white (WBC) and 
red blood cells (RBC), platelets (PLT) and haemoglobin (Hb) were 
calculated for each time point. Significant differences against the 
baseline were assessed by the Mann-Whitney test. Difference between 
the nadir value and the last available value was also tested. 
Results: Results are summarized in Figure 1. Median WBC count at RT 
mid-point and at RT end were 67% and 68% of the baseline, 
respectively. The corresponding values for RBC, PLT and Hb were: 97% 
and 95% for RBC, 89% and 101% for PLT, and 97% and 95% for Hb. When 
focusing on WBC subpopulations, the acute HT was found to be more 
significant: the corresponding median absolute neutrophil and 
lymphocyte counts (ANC and ALC, respectively) were, in fact, 73% and 
80% for ANC, and 38% and 31% for ALC, respectively. For patients with 
data available at 90 days from RT end, the WBC, RBC, PLT, Hb, ANC 
and ALC median values were 73%, 93%, 107%, 97%, 86% and 44% of the 
corresponding baseline. The differences between the nadir and the 
basal value was significant (p≤0.0016) for all parameters except PLT. 
The last available value (end RT or 90 days) was significantly 
increased relative to the nadir value for ALC only (p<0.0001). 
  
Conclusions: A significant blood count reduction, particularly 
significant for ALC, occurs during and immediately after post-
prostatectomy WPRT. Future analyses will focus on the long-term 
recovery of HT on a much larger population as well as on the 
assessment of dosimetry and clinical predictors of HT.  
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Purpose/Objective: To evaluate the genitourinary toxicity and 
chronological changes of the International Prostate Symptom Score 
